Sars Cov1

Showing of 1 - 20 from 2 results
Sars Cov1 - Total results - 2
Unregulated use of plasma therapy for COVID-19 can be harmful, writes expert; can expose patients to serious transfusion-related risks
India

Unregulated use of plasma therapy for COVID-19 can be harmful, writes expert; can expose patients to serious transfusion-related risks

It is a promising solution at the present gloomy situation, but till we have reliable evidence on utility unregulated use is to be avoided

Phase 3 results on Gilead coronavirus drug encouraging; a look at other potential COVID-19 treatments under trial
science

Phase 3 results on Gilead coronavirus drug encouraging; a look at other potential COVID-19 treatments under trial

California-based biotech company Gilead Sciences and the US government reported that in a major study, remdesivir shortened the time it takes for COVID-19 patients to recover by four days on average